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Oral malignant melanomas are aggressive tumors in head and neck region, rarely seen in HIV 
patients. By suppressing immunity, HIV might be increasing the severity of  malignant tumors. 
Oral malignant melanomas are associated with poor prognosis, due to their aggressiveness. Of  
clinical importance, the prognosis of  oral malignant melanomas in HIV patient is still not well 
understood. Presented is a 44-year-old female, HIV seropositive with a swelling on the lower 
lip for five months. Management involved antiretroviral therapy, surgical excision of  the lesion 
and regional lymph nodes, with chemotherapy. Avoidance of  preoperative insult and aggressive 
therapy offers a relatively better prognosis. Irrespective of  lesion size, aggressive treatment is 
needed for oral malignant melanoma.
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Introduction
Human Immunodeficiency Virus (HIV) infection is 
associated with the development of  malignant lesions 
including melanomas.[1] HIV alters the progression 
of  malignant tumors.[2] Oral malignant melanomas 
are rare aggressive neoplasms of  the head and neck 
region,[3] usually associated with poor prognosis. The 
five-year survival rate is below 50%, and it depends on 
stage and site of  the lesions.[4]However, the prognosis 
of  oral melanomas superimposed with HIV infection is 
not yet clear.
Globally, oral malignant melanomas have an incidence 
rate of  0.2% [5] to 8%[4] and account for 1.6% of  all 
head and neck cancers,[5] 2% of  all mucocutaneous 
melanomas[6] and 0.5% of  all oral malignancies.[6] 
About 80% of  all oral melanomas occur on the mucosa 
of  the upper jaw.[3,7] Palate and maxillary gingiva are the 
most commonly affected sites followed by mandibular 
gingiva, buccal mucosa, the floor of  mouth and tongue.
[8] Most affected age is between 40 and 70 years, [8]
occurring more in males than female.[9]  According 
to clinical presentation, melanomas can clinically be 
grouped into three stages. Stage 1, the lesion is localized 
in the primary site, stage 2 the lesion involves lymph 
nodes, and stage 3, the lesion has hematogenous spread.
[4] An HIV seropositive patient with oral malignant 
melanoma confined on the lip is presented.
Case Presentation
A 44-year-old lady reported with five months’ swelling 
on the lower lip. Origin of  the swelling was a small nodule 
that she frequently scratched, and slowly increased in 
size in tandem with time. Two months later she sought 
treatment from the Hospital but disappeared before the 
biopsy was done. She eventually resumed treatment four 
months later. Her husband was deceased four years ago 
with an unconfirmed diagnosis of  HIV. The woman 
appeared with malaise, weak, and pale. Extra-oral 
examination revealed a firm black pedunculated swelling 
on the vermillion border of  the lower lip that extended 
to skin over the lower lip. The swelling measured 5 x 
4 cm in the greatest dimension, ulcerated, non-tender, 
and bled spontaneously. The skin around the swelling 
was black in colour, with covered width of  2 cm from 
the tumor margin. There was a solitary palpable left 
submandibular lymph node that was mobile, non-
tender, and measured 3 cm in greatest dimension. Intra-
oral examination revealed mixed oral lesions of  hairy 
and atrophic candidiasis on the dorsum of  the tongue. 
The rest of  oral mucosa appeared normal. Excision 
biopsy was planned, and the patient transferred for 
HIV serological testing. Antiretroviral drugs were 
initiated immediately after positive HIV test. Patient’s 
general health improved drastically following the use 
of  antiretroviral drugs. This improvement allowed 
progress of  planned excision biopsy. Lesion on the lip 
and submandibular lymph node were widely excised. A 
surgical margin of  1 cm from black pigmentation around 
the swelling was considered. Both specimens were 
delivered for histopathology. The patient was followed 
up to monitor the progress. The histopathological 
results of  tumor on the lip revealed malignant melanoma 
and tumor-free margins.  The lymph node was almost 
entirely invaded by a characteristic melanoma composed 
of  round, oval to spindle cells, very atypical and 
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produced large amounts of  melanin. The lymph node 
capsule was apparently not invaded. The patient was 
sent for adjuvant chemotherapy, tracked for four years 
and afterwards lost to tracking.
Discussion
Co-existence of  HIV and malignant melanoma is 
increasing. The occurrence of  large malignant melanoma 
on the lip is rarely seen. This is the uniqueness of  this 
case report. Oral melanomas are usually diagnosed at 
an advanced stage. Often at this stage, they present as 
an ulcerated, painful, and bleeding swellings.[5,8,9] The 
reported patient in our case, presented with a tumour 5x4 
cm involving submandibular lymph node. Management 
of  aggressive tumours that are diagnosed at advanced 
stage present significant challenges, requiring more 
expertise, and resources, and the prognosis of  the 
patient may not be favourable.
Late diagnosis may be the outcome of  delayed reporting 
for treatment. In this, patient delayed notification and 
withdrawal from treatment were noted.  However, fear 
of  the associated HIV status was the primary cause of  
delayed reporting. This justifies that apparent danger 
of  death and /or extreme discomfort may be possible 
reasons to seek treatment. Lesion on the vermilion 
border and its size is a cosmetic challenge. In this case, a 
patient covered herself  with traditional African Dressing 
famous by the name of  “Khanga”. 
                             
Figure 1. Picture of  the patient before surgery
   
Figure 2. Picture of  the patient after surgery
Oral cavity presents anatomical limitations, which is 
a challenge to achieve surgical clearance of  advanced 
tumor.[8] In this patient, tumor and the palpable 
solitary submandibular lymph node were widely 
excised with a surgical margin of  1 cm from black 
depigmentation. Chemotherapy was considered 
after surgery. Treatment modalities of  primary and 
metastatic melanoma are surgery, radiotherapy, 
chemotherapy, and immunotherapy or a combination 
of  them.[8–10] Melanomas are relatively radioresistant. 
Radiotherapy[10,11] and chemotherapy[4,8,11] 
are not the primary treatment option. Surgery 
performed alone[4] or followed by radiation and /or 
chemotherapy[4,8,11] provides a probability of  cure in 
primary lesions, and in cases of  lymph node involvement. 
Surgery must be done with more than 1-inch (2-5 cm) 
margin of  clinical healthy skin or mucosa for favorable 
results. Radiotherapy is given after surgery, yield good 
results.[4,10] In compromised patients such as elderly or 
those with HIV, chemotherapy is recommended before 
surgery to enable tumor shrinkage.[8] In the presence 
of  metastases, chemotherapy is the cornerstone of  
treatment,[11] making it preferred treatment for stage 
IV melanomas.[8,11] 
Malignant melanomas show good prognosis if  
diagnosed in early stage.[12] Metastasis is seen in late 
stages and occurs through hematogenous, lymphatic, 
perineural and trans-ductal routes.[13] In the advanced 
stage, median survival is two years, while the 5-year 
prognosis is sometimes less than 20%.[14] Some patients 
are reported to die within few months after initiation of  
treatment.[12] Mystically, the patient survived four years 
without complications. Probably avoidance of  incisional 
biopsy, wide excision of  the tumor, and the palpable 
solitary submandibular lymph node, and postoperative 
chemotherapy may be the reasons behind such relatively 
better patient survival. 
Conclusion
Avoidance of  preoperative incisional biopsy is crucial 
for the benefit of  a melanoma patient.  The site of  the 
lesion may contribute to the prognosis of  the patient. 
Lesion on the lip may not be as aggressive as those on the 
gums or palate. All melanoma must receive aggressive 
treatment. Achieving total tumor clearance by surgery 
must be the objective of  treatment irrespective of  the 
size, and site of  the lesion and immunological status of  
the patient. 
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